Sign up Australia
Proactive Investors - Run By Investors For Investors

Cann Group secures license to import/export medicinal cannabis products

Planning to import medicinal cannabis products for supply to Australian patients.
cannabis leaves
Cann is working with Canadian companies

Cann Group Ltd (ASX:CAN) has been granted a licence to import and export cannabis genetics and medicinal cannabis products by the Office of Drug Control, Australian Department of Health.

As a holder of this licence, the company can now apply for a permit to export raw cannabis material and cannabis oil for analytical testing.

Cann intends to utilise the analytical services of Anandia Laboratories in Canada to complement the capabilities available to the company in Australia.

The licence also allows Cann to apply for a permit to import cannabis genetics and medicinal cannabis products from legal international sources.

Cann is working closely with Canadian companies Aurora Cannabis and Anandia Laboratories to identify suitable genetics and medicinal cannabis products for inclusion in an import permit application.

The company is aiming to submit the application soon to facilitate the process of obtaining export approvals with Health Canada.

The granting of the new licence is an important milestone for Cann in building a genetic database of locally and internationally sourced cannabis strains for cultivation under its medicinal cannabis licence.

Similarly, the import/export licence is a key step in the company’s plans to import medicinal cannabis products for supply to Australian patients to complement locally manufactured products.

View full CAN profile View Profile

Cann Group Ltd Timeline

Related Articles

picture of genes
November 29 2017
Among those cited as using Silence’s tech is US firm Alnylam, valued at US$12.7bn.
April 01 2018
The company is in the process of raising £5mln, with a possible further £1mln through a share issue at 52.5p
scientist looking through a microscope
November 01 2017
As of March, ReNeuron had £53mln in cash equivalents but its market value is not too much above that....

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use